6 Recommendations for further research

6 Recommendations for further research

6.1 The clinical efficacy and safety of thrombolysis with alteplase for acute ischaemic stroke is being assessed outside of its current marketing authorisation, specifically in patients aged up to 80 years and up to 6 hours from onset of stroke symptoms (the third International Stroke Trial [IST-3]).

  • National Institute for Health and Care Excellence (NICE)